, Tracking Stock Market Picks
Enter Symbol:
Adma Biologics (ADMA) [hlAlert]

down 14.66 %

Adma Biologics (ADMA) rated Outperform with price target $20 by Oppenheimer

Posted on: Monday,  Dec 8, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Adma Biologics (NASDAQ: ADMA) on 12/08/2014, when the stock price was $10.84. Since
then, Adma Biologics has lost 14.67% as of 08/27/2015's recent price of $9.25.
If you would have followed this Oppenheimer's recommendation on ADMA, you would have lost 14.66% of your investment in 262 days.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/8/2014 8:25 AM Buy
10.84 20.00
as of 8/27/2015
1 Week down  -0.21 %
1 Month up  9.98 %
3 Months up  12.12 %
1 YTD down  -14.66 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy